GALT
Galectin Therapeutics Inc
$2.33-0.04 (-1.69%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
Insider Activity
1 of 169 tradesExecutives investing their own money
🤖 AI InsightHaiku 4.5
GALECTIN THERAPEUTICS INC (GALT) is a publicly traded company with 2 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 2 unique insiders. All recorded transactions were open-market purchases, with insiders buying a combined $810 of stock — a directionally bullish signal when no offsetting sales occur. The largest single purchase was made by ELDRED KARY on Feb 6, 2026 for $810. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
Showing 10 of 169 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-17 | 2026-03-12 | Brem Henry | Director | Award | 60,000 | $3.16 | $189,600 | N/A | N/A |
| 2026-02-09 | 2026-02-06 | Eldred Kary | Director | Purchase | 300 | $2.70 | $810 | +2.2% | +24.1% |
| 2026-01-13 | 2026-01-05 | Lewis Joel | CEO | Unknown | 56,332 | $3.88 | -$218,568 | N/A | N/A |
| 2026-01-06 | 2026-01-06 | Lewis Joel | CEO | Sale | 37,698 | $3.58 | -$134,846 | N/A | N/A |
| 2026-01-06 | 2026-01-06 | Callicutt Jack W | CFO | Sale | 20,354 | $3.67 | -$74,699 | N/A | N/A |
| 2026-01-06 | 2026-01-06 | Jamil Khurram | CMO | Sale | 21,446 | $3.65 | -$78,214 | N/A | N/A |
| 2026-01-06 | 2026-01-05 | Callicutt Jack W | CFO | Sale | 25,732 | $3.90 | -$100,303 | N/A | N/A |
| 2026-01-06 | 2026-01-05 | Lewis Joel | CEO | Sale | 27,731 | $3.91 | -$108,345 | N/A | N/A |
| 2026-01-06 | 2026-01-05 | Jamil Khurram | CMO | Sale | 25,499 | $3.90 | -$99,421 | N/A | N/A |
| 2026-01-06 | 2026-01-02 | Jamil Khurram | CMO | Exercise Conversion | 60,000 | $0.00 | $0 | N/A | N/A |
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.